DaVita: Move To Stop Helping ESRD Patients Get Assistance For Private Coverage Temporary, Cost Implications Overblown

Updated Story DaVita officials provided investors with more insight into the company's decision to immediately stop helping Medicaid-eligible patients get additional exchange coverage with the help of the American Kidney Fund, while also arguing the assistance efforts have only slightly increased end-stage renal disease-related plan spending despite insurers' assertions to the contrary. In a Wednesday call, DaVita officials said their move was only temporary and would be reevaluated once CMS releases additional guidance. DaVita made the decision...